Life Science Compliance Update



A New Round of Efforts to Reform 340b: Part I, Program Transparency

Written by , Posted in Uncategorized

By Gwendolyn Ball

Ever since the creation of the 340B discount program, it has been plagued by transparency issues. Current efforts to curb pharmaceutical prices have only served to resurface these unresolved issues. This article, the first of two parts, will explore the latest developments to address 340B transparency.


  • Return to September 2018 LSC Update Table of Contents
  • Copy abstract URL
  • Order Reprints
  • Topic tags:

    Menu Title